Among the tumour-infiltrating myeloid (CD11b+) cells, our results indicate that the major proportion of these infiltrated CD11b+ cells are ILK+ compared to the ILK-deficient myeloid cells which are comparable to those in adjacent normal tissues (Figures 7C, D), suggesting myeloid-ILK as a prognostic marker for CRC in humans. The gene discussed is ILK; the disease is neoplasm.